Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Collagen microparticles: preparation and properties

B Rössler1, J Kreuter, D Scherer

  • 1Institute of Pharmaceutical Technology, J. W. Goethe University, Frankfurt/Main, Germany.

Journal of Microencapsulation
|January 1, 1995
PubMed
Summary

Collagen microparticles (CMPs) were created using controlled denaturation for precise size control, ranging from 0.1 to 40 microns. These biodegradable and thermally stable CMPs effectively carry lipophilic drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observing the tidal pulse of rivers from wide-swath satellite altimetry.

Nature·2026
Same author

A Low Concentration of Tacrolimus/Semifluorinated Alkane (SFA) Eyedrop Suppresses Intraocular Inflammation in Experimental Models of Uveitis.

Current molecular medicine·2017
Same author

The 'HLA conundrum in bone marrow transplantation': correct interpretation of anti-HLA antibodies in haploidentical donor selection.

Bone marrow transplantation·2017
Same author

Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer.

Journal of controlled release : official journal of the Controlled Release Society·2015
Same author

Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.

The pharmacogenomics journal·2015
Same author

Arylsulfatase A bound to poly(butyl cyanoacrylate) nanoparticles for enzyme replacement therapy--physicochemical evaluation.

Die Pharmazie·2014

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Nanotechnology

Background:

  • Collagen microparticles (CMPs) are biocompatible materials with potential applications in drug delivery.
  • Controlling the size of CMPs is crucial for optimizing their performance as drug carriers.
  • Native collagen requires specific processing to yield microparticles of desired dimensions.

Purpose of the Study:

  • To develop a method for controlling the size of collagen microparticles (CMPs).
  • To investigate the use of CMPs as carriers for lipophilic drugs.
  • To evaluate the properties of CMPs, including biodegradability and thermal stability.

Main Methods:

  • Preparation of CMPs via emulsifying and cross-linking native collagen.
  • Control of particle size through collagen molecular weight and degree of denaturation.

Related Experiment Videos

  • Characterization of particle size distribution and drug-loading capacity.

    • Main Results:

    • CMPs with diameters ranging from 3 to 40 microns were successfully prepared.
    • Controlled denaturation of collagen was identified as the primary method for size control.
    • Total denaturation yielded nanoparticles as small as 0.1 micron.
    • CMPs demonstrated efficacy in carrying lipophilic drugs like retinol and tretinoin.
    • The biodegradable CMPs exhibited excellent thermal stability, facilitating sterilization.

    Conclusions:

    • Controlled denaturation of collagen provides a reliable method for producing CMPs of specific sizes.
    • CMPs are versatile biodegradable carriers suitable for various lipophilic drugs.
    • The thermal stability of CMPs simplifies their sterilization for pharmaceutical applications.